Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues
September 21 2021 - 6:59PM
Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and
innovator in brachytherapy powering expanding treatment options
throughout the body, will host a rescheduled conference call to
discuss its financial results for the fourth quarter and fiscal
year ended June 30, 2021 on Wednesday, September 22, 2021, at 10:00
a.m. Eastern Time/7:00 a.m. Pacific.
The rescheduled conference call was necessitated by the
conference bridge provider’s technical failure. The Company has
already issued a press release announcing its financial results for
the fourth quarter and fiscal year ended June 30, 2021. The press
release was issued after the close of the U.S. stock markets on
September 21, 2021.
To listen to the conference call, please dial 888-506-0062. For
callers outside the U.S., please dial 973-528-0011.
The conference call will be simultaneously webcast and can be
accessed at
https://www.webcaster4.com/Webcast/Page/2199/42976. The webcast
will be available until December 22, 2021 following the conference
call.
About
IsorayIsoray, Inc. is a
medical technology company pioneering advanced treatment
applications and devices to deliver targeted internal radiation
treatments for cancers throughout the body. Isoray, Inc., through
its subsidiary, Isoray Medical, Inc., is the sole producer of
Cesium-131 brachytherapy seeds. Learn more about this innovative
Richland, Washington company and explore the many benefits and uses
of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and
Twitter.
Contact:
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Mar 2024 to Apr 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Apr 2023 to Apr 2024